Back to results
US 6,608,031 B1Granted
Insulin-like growth factor agonist molecules
AssigneeGenentech, Inc.
InventorsRoss G. Clark, Henry B. Lowman, Iain C. A. F. Robinson
Life of this patent
Estimating the term…
Abstract
Compounds are provided that inhibit the interaction of an IGF with any one of its binding proteins and not to a human IGF receptor. These IGF agonist compounds, which include peptides, are useful to increase serum and tissue levels of active IGFs in a mammal.
Claims7
A peptide comprising an amino acid sequence that is SEQ ID NO:109.
Dependencies are inferred from the claim text.